Hospital Sant Joan de Déu Barcelona is a teaching hospital specializing in the fields of pediatrics, gynecology and obstetrics. It is located on Passeig Sant Joan de Déu in Esplugues de Llobregat, a municipality bordering Barcelona, Catalonia.

During the past decade, Hospital Sant Joan de Déu conducted 158 clinical trials. In the 10-year time frame, 158 clinical trials started and 40 clinical trials were completed, i.e. on average, 25.3% percent of trials that started reached the finish line to date. In the past 5 years, 87 clinical trials started and 29 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Sant Joan de Déu" #1 sponsor was "Fundació Sant Joan de Déu" with 16 trials, followed by "Hoffmann-La Roche" with 15 trials sponsored, "Eli Lilly and Company" with 13 trials sponsored, "PTC Therapeutics" with 9 trials sponsored and "Amgen" with 9 trials sponsored. Other sponsors include 131 different institutions and companies that sponsored additional 83 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Sant Joan de Déu" #1 collaborator was "Hospital Sant Joan de Deu" with 8 trials as a collaborator, "Fundació Sant Joan de Déu" with 4 trials as a collaborator, "Instituto de Salud Carlos III" with 3 trials as a collaborator, "Nippon Shinyaku Co., Ltd." with 3 trials as a collaborator and "ADIR, a Servier Group company" with 2 trials as a collaborator. Other collaborators include 195 different institutions and companies that were collaborators in the rest 187 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Sant Joan de Déu" are "Duchenne Muscular Dystrophy" (12 trials), "Muscular Atrophy, Spinal" (7 trials), "Cystic Fibrosis" (6 trials), "Neuroblastoma" (5 trials) and "Neuromuscular Diseases" (5 trials). Many other conditions were trialed in "Hospital Sant Joan de Déu" in a lesser frequency.

Most popular intervention types in "Hospital Sant Joan de Déu" are "Drug" (142 trials), "Other" (21 trials), "Biological" (16 trials), "Dietary Supplement" (7 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (49 trials), "Ataluren" (5 trials), "Baricitinib" (5 trials), "Cyclophosphamide" (5 trials) and "ELX/TEZ/IVA" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Sant Joan de Déu" are 170 trials for "All" genders, 17 trials for "Male" genders and 9 trials for "Female" genders.

Currently, there are 92 active trials in "Hospital Sant Joan de Déu". 2 are not yet recruiting, 60 are recruiting, 28 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 78 completed trials in Hospital Sant Joan de Déu, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Sant Joan de Déu, 20 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 84 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 18 trials that are defined as “Not Applicable".

Hospital Sant Joan de Déu has several departments that took part in Clinical trials: "Anesthesia department, Hospital Clínic de Barcelona" - 4 trials, "Hospital Sant Joan De Deu; Servicio de Reumatologia Pediatrica" - 3 trials, "Hospital Sant Joan de Déu Barcelona Unidad de Enfermedades Neuromusculares" - 2 trials, "Teaching, Research & Innovation Unit - Parc Sanitari Sant Joan de Déu" - 2 trials, "Hospital Sant Joan de Deu - PIN; Unitat de Recerca - Farmacia" - 2 trials, "Department of Child and Adolescent Pyshicatry and Psychology" - 2 trials, "Hospital Sant Joan de Deu; Servicio de Oncologia y Hematologia" - 2 trials